DPIIT recognised startup Government of India
Startup India
Convergent Biosciences Private Limited - life sciences in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.66 Lakh
▼ 86% YoY
Net loss · FY 2025
₹3.02 Lakh
Net margin -113.5%
EBITDA · FY 2025
-₹85,800
EBITDA margin -32.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Convergent Biosciences Private Limited
Data last updated:
Convergent Biosciences Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 07 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2019PTC134671. Its GSTIN is 36AAICC3186E1ZO (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sridhar Kumar Chitneni and Vangapandu Sashi Bhushan Rao.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 8 Srila Park Pride Vasanth Nagar Kphb Colony, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.66 Lakh, a decline of 86% compared to the previous year. For the same year it recorded a net loss of ₹3.02 Lakh (net margin -113.5%) and EBITDA of -₹85,800 (EBITDA margin -32.3%). Revenue has declined at a compounded annual rate (CAGR) of 55% over three years.
For more details, the company can be reached via its website convergentbiosciences.com.
Company details
CIN U73100TG2019PTC134671
Registration Number 134671
Incorporation Date 07 August 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Convergent Biosciences
Contact details
Convergent Biosciences Private Limited's registered office is in Hyderabad, Telangana. Its website is convergentbiosciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS – 8 Srila Park Pride Vasanth Nagar Kphb Colony, Hyderabad, Telangana, India – 500072
- IndustryLife Sciences, Biotechnology
To see the full contact details of Convergent Biosciences Private Limited, buy the company report.
Comprehensive company report
Convergent Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Convergent Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Convergent Biosciences Private Limited, buy the company report.
Financials of Convergent Biosciences Private Limited
FY 2025 filings availableConvergent Biosciences Private Limited reported revenue of ₹2.66 Lakh (down 86% YoY) for FY 2025.
Revenue · FY 2025
₹2.66 Lakh ▼ 86%
Net loss · FY 2025
₹3.02 Lakh margin -113.5%
EBITDA · FY 2025
-₹85,800 margin -32.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 86%
3 years · compounded
▼ 55%
EBITDA CAGR growth
1 year
▲ 90%
3 years · compounded
▼ 30%
5 years · compounded
▼ 42%
Revenue has declined at a compounded annual rate (CAGR) of 55% over three years, including a 86% fall in the latest year. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹85,800 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -32.3% | ||||
| Net Profit Margin | -113.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Convergent Biosciences Private Limited, buy the company report.
Board of directors of Convergent Biosciences Private Limited
Convergent Biosciences has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sridhar Kumar Chitneni | Director | 12 Jul 2023 | 3 Years 3 Months | Current |
| Vangapandu Sashi Bhushan Rao Also directs: Eliciton Innovations Private Limited, GKR Biotech Private Limited | Director | 07 Aug 2019 | 7 Years 2 Months | Current |
Shareholding
The shareholding of Convergent Biosciences Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Convergent Biosciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Convergent Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Convergent Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Convergent Biosciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICC3186E1ZO | Telangana | Active | 03 Jul 2020 |
To see the full GST registrations and return filing status of Convergent Biosciences Private Limited, buy the company report.
Recent activity
Convergent Biosciences Private Limited has 7 board changes on record since 2019: 2 appointments and 5 cessations. The latest: Sridhar Kumar Chitneni ceased to be Additional Director on 29 Sep 2023.
AGM
Convergent Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Convergent Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Sridhar Kumar Chitneni ceased to be Additional Director.
Appointed
Sridhar Kumar Chitneni was appointed as Director.
Ceased
Srivalli Ogireddy ceased to be Director.
Ceased
Nagaraju Shiva Rama Krishnam Raju ceased to be Director.
Ceased
Sunita Gorthy ceased to be Director.
Ceased
Paidikondala Kishore Kumar ceased to be Director.
Appointed
Vangapandu Sashi Bhushan Rao was appointed as Director.
Incorporation
07 Aug 2019
Convergent Biosciences Private Limited was registered on 07 Aug 2019 with Roc Hyderabad & aged 7 years 2 months as per MCA records.
Frequently asked questions
Convergent Biosciences is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 07 August 2019 (7+ years old) and is registered under CIN U73100TG2019PTC134671.
Convergent Biosciences has 2 current directors:
- Sridhar Kumar Chitneni - Director
- Vangapandu Sashi Bhushan Rao - Director
The latest financial statements of Convergent Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Convergent Biosciences is 36AAICC3186E1ZO, registered in Telangana.
The CIN (Corporate Identification Number) of Convergent Biosciences is U73100TG2019PTC134671. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Convergent Biosciences was incorporated on 07 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sridhar Kumar Chitneni ceased to be Additional Director on 29 Sep 2023. Sridhar Kumar Chitneni was appointed as Director on 12 Jul 2023. Srivalli Ogireddy ceased to be Director on 12 Jul 2023. Convergent Biosciences has 7 board changes on record in total.
Yes, Convergent Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Convergent Biosciences can be reached through the website convergentbiosciences.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Convergent Biosciences is at S – 8 Srila Park Pride Vasanth Nagar Kphb Colony, Hyderabad, Telangana, India – 500072.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages